A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena

Fertility and Sterility

Volumn 97, Issue 3, 2012, Pages

  Gemzell Danielsson, Kristina ^a   Schellschmidt, Ilka ^b   Apter, Dan ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b BAYER AG   (Germany)

^c Sexual Health Clinic   (Finland)

Author keywords

bleeding pattern; Contraception; levonorgestrel releasing intrauterine system; LNG IUS; placement

Indexed keywords

LEVONORGESTREL;

ABDOMINAL PAIN; ACNE; ADULT; ARTICLE; BREAST ENGORGEMENT; CONTROLLED STUDY; DEVICE SAFETY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSMENORRHEA; EDEMA; FEMALE; HEADACHE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LOW DRUG DOSE; LOWER ABDOMINAL PAIN; MASTALGIA; MOOD CHANGE; NAUSEA; OVARY CYST; PAIN ASSESSMENT; PHASE 2 CLINICAL TRIAL; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEBORRHEA; SIDE EFFECT; SPOTTING; STOMACH DISTENSION; VAGINA BLEEDING; VAGINA CANDIDIASIS; VAGINITIS; WEIGHT GAIN;

EID: 84857790111     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.12.003     Document Type: Article

References (17)

1. K. Andersson, V. Odlind, and G. Rybo Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial Contraception 49 1994 56 72
2. T. Backman, I. Rauramo, S. Huhtala, and M. Koskenvuo Pregnancy during the use of levonorgestrel intrauterine system Am J Obstet Gynecol 190 2004 50 54
3. M. Cox, J. Tripp, and S. Blacksell Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report J Fam Plann Reprod Health Care 28 2002 73 77
4. D. Mansour, P. Inki, and K. Gemzell-Danielsson Efficacy of contraceptive methods: a review of the literature Eur J Contracept Reprod Health Care 15 2010 4 16
5. I. Sivin, S. el Mahgoub, T. McCarthy, D.R. Mishell Jr., D. Shoupe, and F. Alvarez Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study Contraception 42 1990 361 378
6. Bayer HealthCare Pharmaceuticals Inc. Mirena® (levonorgestrel- releasing intrauterine system). Summary of product characteristics. 2009. Available at: External link http://www.berlex.com/html/products/pi/Mirena-PI. pdf. Accessed August 2, 2011.
7. R. Canteiro, M.V. Bahamondes, A. dos Santos Fernandes, X. Espejo-Arce, N.M. Marchi, and L. Bahamondes Length of the endometrial cavity as measured by uterine sounding and ultrasonography in women of different parities Contraception 81 2010 515 519
8. ® LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women Contraception 81 2010 367 371
9. C. Gerlinger, J. Endrikat, E.A. van der Meulen, T.O. Dieben, and B. Düsterberg Recommendation for confidence interval and sample size calculation for the Pearl Index Eur J Contracept Reprod Health Care 8 2003 87 92
10. E.M. Belsey, D. Machin, and C. d'Arcangues The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction Contraception 34 1986 253 260
11. World Health Organization Microdose intrauterine levonorgestrel for contraception. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Intrauterine Devices for Fertility Regulation Contraception 35 1987 363 379
12. M. Heikkilä, P. Lähteenmäki, and T. Luukkainen Immediate postabortal insertion of a levonorgestrel-releasing IUD Contraception 26 1982 245 259
13. S.G. Silverberg, M. Haukkamaa, H. Arko, C.G. Nilsson, and T. Luukkainen Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices Int J Gynecol Pathol 5 1986 235 241
14. O. Heikinheimo, P. Inki, M. Kunz, and K. Gemzell-Danielsson Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system Hum Reprod 25 2010 1423 1427
15. G.E. Robinson, W. Bounds, A.A. Kubba, J. Adams, and J. Guillebaud Functional ovarian cysts associated with the levonorgestrel-releasing intrauterine device Br J Fam Plann 14 1989 131 132
16. K. Gemzell-Danielsson, P. Inki, L. Boubli, M. O'Flynn, M. Kunz, and O. Heikinheimo Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS) - a multicentre prospective study Hum Reprod 25 2010 354 359
17. S. Suhonen, M. Haukkamaa, T. Jakobsson, and I. Rauramo Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study Contraception 69 2004 407 412